-
2
-
-
48049084164
-
Molecular characterization of pancreatic neoplasms
-
Shi C, Daniels JA, Hruban RH. Molecular characterization of pancreatic neoplasms. Adv Anat Pathol 2008;15:185-95.
-
(2008)
Adv Anat Pathol
, vol.15
, pp. 185-195
-
-
Shi, C.1
Daniels, J.A.2
Hruban, R.H.3
-
3
-
-
79952279828
-
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors
-
Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011;331: 1199-203.
-
(2011)
Science
, vol.331
, pp. 1199-1203
-
-
Jiao, Y.1
Shi, C.2
Edil, B.H.3
De Wilde, R.F.4
Klimstra, D.S.5
Maitra, A.6
-
4
-
-
52149123619
-
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
-
Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321:1801-6.
-
(2008)
Science
, vol.321
, pp. 1801-1806
-
-
Jones, S.1
Zhang, X.2
Parsons, D.W.3
Lin, J.C.4
Leary, R.J.5
Angenendt, P.6
-
5
-
-
84862907854
-
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways
-
Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A 2011;108:21188-93.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 21188-21193
-
-
Wu, J.1
Jiao, Y.2
Dal Molin, M.3
Maitra, A.4
De Wilde, R.F.5
Wood, L.D.6
-
6
-
-
79960660466
-
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development
-
Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011;3: 92ra66.
-
(2011)
Sci Transl Med
, vol.3
-
-
Wu, J.1
Matthaei, H.2
Maitra, A.3
Dal Molin, M.4
Wood, L.D.5
Eshleman, J.R.6
-
7
-
-
77951115122
-
International Cancer Genome Consortium. International network of cancer genome projects
-
Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, et al. International Cancer Genome Consortium. International network of cancer genome projects. Nature 2010;464:993-8.
-
(2010)
Nature
, vol.464
, pp. 993-998
-
-
Hudson, T.J.1
Anderson, W.2
Artez, A.3
Barker, A.D.4
Bell, C.5
Bernabé, R.R.6
-
8
-
-
56649085104
-
Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas
-
Hong SM, Kelly D, Griffith M, Omura N, Li A, Li CP, et al. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Mod Pathol 2008;21:1499-507.
-
(2008)
Mod Pathol
, vol.21
, pp. 1499-1507
-
-
Hong, S.M.1
Kelly, D.2
Griffith, M.3
Omura, N.4
Li, A.5
Li, C.P.6
-
9
-
-
77949564293
-
Aberrant microRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma
-
Ryu JK, Hong SM, Karikari CA, Hruban RH, Goggins MG, Maitra A. Aberrant microRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology 2010;10:66-73.
-
(2010)
Pancreatology
, vol.10
, pp. 66-73
-
-
Ryu, J.K.1
Hong, S.M.2
Karikari, C.A.3
Hruban, R.H.4
Goggins, M.G.5
Maitra, A.6
-
10
-
-
0037742210
-
Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays
-
Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, et al. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 2003;63:3735-42.
-
(2003)
Cancer Res
, vol.63
, pp. 3735-3742
-
-
Sato, N.1
Fukushima, N.2
Maitra, A.3
Matsubayashi, H.4
Yeo, C.J.5
Cameron, J.L.6
-
11
-
-
84865103094
-
Conceptual framework for cutting the pancreatic cancer fuel supply
-
Le A, Rajeshkumar NV, Maitra A, Dang CV. Conceptual framework for cutting the pancreatic cancer fuel supply. Clin Cancer Res 2012;18:4285-90.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4285-4290
-
-
Le, A.1
Rajeshkumar, N.V.2
Maitra, A.3
Dang, C.V.4
-
12
-
-
33646231772
-
Pancreatic Cancer Genetic Epidemiology (PACGENE) Consortium
-
Pancreatic cancer genetic epidemiology consortium
-
Petersen GM, de Andrade M, Goggins M, Hruban RH, Bondy M, Korczak JF, et al. Pancreatic Cancer Genetic Epidemiology (PACGENE) Consortium. Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2006;15:704-10.
-
(2006)
Cancer Epidemiol Biomarkers Prev
, vol.15
, pp. 704-710
-
-
Petersen, G.M.1
De Andrade, M.2
Goggins, M.3
Hruban, R.H.4
Bondy, M.5
Korczak, J.F.6
-
13
-
-
28044444895
-
Treatment of familial pancreatic cancer and its precursors
-
Hruban RH, Canto MI, Griffin C, Kern SE, Klein AP, Laheru D, et al. Treatment of familial pancreatic cancer and its precursors. Curr Treat Options Gastroenterol 2005;8:365-75.
-
(2005)
Curr Treat Options Gastroenterol
, vol.8
, pp. 365-375
-
-
Hruban, R.H.1
Canto, M.I.2
Griffin, C.3
Kern, S.E.4
Klein, A.P.5
Laheru, D.6
-
14
-
-
11144353646
-
Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds
-
Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004;64:2634-8.
-
(2004)
Cancer Res
, vol.64
, pp. 2634-2638
-
-
Klein, A.P.1
Brune, K.A.2
Petersen, G.M.3
Goggins, M.4
Tersmette, A.C.5
Offerhaus, G.J.6
-
16
-
-
22244467729
-
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: A combined analysis of 22 population based studies
-
Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 2005;42:602-3.
-
(2005)
J Med Genet
, vol.42
, pp. 602-603
-
-
Antoniou, A.C.1
Pharoah, P.D.2
Narod, S.3
Risch, H.A.4
Eyfjord, J.E.5
Hopper, J.L.6
-
17
-
-
1442307845
-
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literature
-
Liede A, Karlan BY, Narod SA. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 2004;22:735-42.
-
(2004)
J Clin Oncol
, vol.22
, pp. 735-742
-
-
Liede, A.1
Karlan, B.Y.2
Narod, S.A.3
-
18
-
-
0034926689
-
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
-
Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 2001;10:467-73.
-
(2001)
Cancer Epidemiol Biomarkers Prev
, vol.10
, pp. 467-473
-
-
Satagopan, J.M.1
Offit, K.2
Foulkes, W.3
Robson, M.E.4
Wacholder, S.5
Eng, C.M.6
-
19
-
-
24944434401
-
Cancer risks in BRCA2 families: Estimates for sites other than breast and ovary
-
Netherlands Collaborative Group on Hereditary Breast Cancer (HEBON)
-
van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HF, et al. Netherlands Collaborative Group on Hereditary Breast Cancer (HEBON). Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 2005;42:711-9.
-
(2005)
J Med Genet
, vol.42
, pp. 711-719
-
-
Van Asperen, C.J.1
Brohet, R.M.2
Meijers-Heijboer, E.J.3
Hoogerbrugge, N.4
Verhoef, S.5
Vasen, H.F.6
-
20
-
-
17244375049
-
Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase
-
Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase. Nature 2005;434:913-7.
-
(2005)
Nature
, vol.434
, pp. 913-917
-
-
Bryant, H.E.1
Schultz, N.2
Thomas, H.D.3
Parker, K.M.4
Flower, D.5
Lopez, E.6
-
21
-
-
25444471892
-
Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy
-
Helleday T, Bryant HE, Schultz N. Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy. Cell Cycle 2005;4:1176-8.
-
(2005)
Cell Cycle
, vol.4
, pp. 1176-1178
-
-
Helleday, T.1
Bryant, H.E.2
Schultz, N.3
-
22
-
-
33748065304
-
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
-
McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, et al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res 2006;66:8109-15.
-
(2006)
Cancer Res
, vol.66
, pp. 8109-8115
-
-
McCabe, N.1
Turner, N.C.2
Lord, C.J.3
Kluzek, K.4
Bialkowska, A.5
Swift, S.6
-
23
-
-
64849092309
-
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
-
Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009;324:217.
-
(2009)
Science
, vol.324
, pp. 217
-
-
Jones, S.1
Hruban, R.H.2
Kamiyama, M.3
Borges, M.4
Zhang, X.5
Parsons, D.W.6
-
24
-
-
77957333720
-
PALB2 mutations in European familial pancreatic cancer families
-
Slater EP, Langer P, Niemczyk E, Strauch K, Butler J, Habbe N, et al. PALB2 mutations in European familial pancreatic cancer families. Clin Genet 2010;78:490-4.
-
(2010)
Clin Genet
, vol.78
, pp. 490-494
-
-
Slater, E.P.1
Langer, P.2
Niemczyk, E.3
Strauch, K.4
Butler, J.5
Habbe, N.6
-
25
-
-
78751559414
-
Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer
-
Villarroel MC, Rajeshkumar NV, Garrido-Laguna I, De Jesus-Acosta A, Jones S, Maitra A, et al. Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer. Mol Cancer Ther 2011;10:3-8.
-
(2011)
Mol Cancer Ther
, vol.10
, pp. 3-8
-
-
Villarroel, M.C.1
Rajeshkumar, N.V.2
Garrido-Laguna, I.3
De Jesus-Acosta, A.4
Jones, S.5
Maitra, A.6
-
26
-
-
84863830403
-
ATM mutations in patients with hereditary pancreatic cancer
-
Roberts NJ, Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy ML, et al. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2012;2:41-6.
-
(2012)
Cancer Discov
, vol.2
, pp. 41-46
-
-
Roberts, N.J.1
Jiao, Y.2
Yu, J.3
Kopelovich, L.4
Petersen, G.M.5
Bondy, M.L.6
-
27
-
-
3242744313
-
An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms
-
Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-87.
-
(2004)
Am J Surg Pathol
, vol.28
, pp. 977-987
-
-
Hruban, R.H.1
Takaori, K.2
Klimstra, D.S.3
Adsay, N.V.4
Albores-Saavedra, J.5
Biankin, A.V.6
-
28
-
-
0142072036
-
Clinicopathological correlates of pancreatic intraepithelial neoplasia: A comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma
-
Andea A, Sarkar F, Adsay VN. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003;16:996-1006.
-
(2003)
Mod Pathol
, vol.16
, pp. 996-1006
-
-
Andea, A.1
Sarkar, F.2
Adsay, V.N.3
-
30
-
-
84862777152
-
Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia
-
Kanda M, Matthaei H, Wu J, Hong SM, Yu J, Borges M, et al. Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 2012;142:730-3, e9.
-
(2012)
Gastroenterology
, vol.142
-
-
Kanda, M.1
Matthaei, H.2
Wu, J.3
Hong, S.M.4
Yu, J.5
Borges, M.6
-
31
-
-
78049398107
-
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
-
Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467:1114-7.
-
(2010)
Nature
, vol.467
, pp. 1114-1117
-
-
Yachida, S.1
Jones, S.2
Bozic, I.3
Antal, T.4
Leary, R.5
Fu, B.6
-
32
-
-
62249176551
-
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer
-
Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 2009;27:1806-13.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1806-1813
-
-
Iacobuzio-Donahue, C.A.1
Fu, B.2
Yachida, S.3
Luo, M.4
Abe, H.5
Henderson, C.M.6
-
33
-
-
84856082746
-
Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies
-
Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 2012;148:362-75.
-
(2012)
Cell
, vol.148
, pp. 362-375
-
-
Haeno, H.1
Gonen, M.2
Davis, M.B.3
Herman, J.M.4
Iacobuzio-Donahue, C.A.5
Michor, F.6
-
35
-
-
79960700556
-
Altered telomeres in tumors with ATRX and DAXX mutations
-
Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011;333:425.
-
(2011)
Science
, vol.333
, pp. 425
-
-
Heaphy, C.M.1
De Wilde, R.F.2
Jiao, Y.3
Klein, A.P.4
Edil, B.H.5
Shi, C.6
-
36
-
-
79851500081
-
RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group. Everolimus for advanced pancreatic neuroendocrine tumors
-
Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, et al. RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011;364:514-23.
-
(2011)
N Engl J Med
, vol.364
, pp. 514-523
-
-
Yao, J.C.1
Shah, M.H.2
Ito, T.3
Bohas, C.L.4
Wolin, E.M.5
Van Cutsem, E.6
-
37
-
-
0036120621
-
Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: Frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway
-
Abraham SC, Wu TT, Hruban RH, Lee JH, Yeo CJ, Conlon K, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 2002;160:953-62.
-
(2002)
Am J Pathol
, vol.160
, pp. 953-962
-
-
Abraham, S.C.1
Wu, T.T.2
Hruban, R.H.3
Lee, J.H.4
Yeo, C.J.5
Conlon, K.6
-
38
-
-
0027718103
-
Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation
-
Hoorens A, Lemoine NR, McLellan E, Morohoshi T, Kamisawa T, Heitz PU, et al. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 1993;143:685-98.
-
(1993)
Am J Pathol
, vol.143
, pp. 685-698
-
-
Hoorens, A.1
Lemoine, N.R.2
McLellan, E.3
Morohoshi, T.4
Kamisawa, T.5
Heitz, P.U.6
-
39
-
-
0028087719
-
Only wild-type c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas
-
Terhune PG, Heffess CS, Longnecker DS. Only wild-type c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas. Mol Carcinog 1994;10:110-4.
-
(1994)
Mol Carcinog
, vol.10
, pp. 110-114
-
-
Terhune, P.G.1
Heffess, C.S.2
Longnecker, D.S.3
-
40
-
-
78249247414
-
Germline Brca2 heterozygosity promotes Kras(G12D)-driven carcinogenesis in a murine model of familial pancreatic cancer
-
Skoulidis F, Cassidy LD, Pisupati V, Jonasson JG, Bjarnason H, Eyfjord JE, et al. Germline Brca2 heterozygosity promotes Kras(G12D)-driven carcinogenesis in a murine model of familial pancreatic cancer. Cancer Cell 2010;18:499-509.
-
(2010)
Cancer Cell
, vol.18
, pp. 499-509
-
-
Skoulidis, F.1
Cassidy, L.D.2
Pisupati, V.3
Jonasson, J.G.4
Bjarnason, H.5
Eyfjord, J.E.6
-
41
-
-
84865062750
-
Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas
-
Hidalgo M, Von Hoff DD. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas. Clin Cancer Res 2012;18:4249-56.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4249-4256
-
-
Hidalgo, M.1
Von Hoff, D.D.2
-
42
-
-
51349147652
-
Prevalence of unsuspected pancreatic cysts on MDCT
-
Laffan TA, Horton KM, Klein AP, Berlanstein B, Siegelman SS, Kawamoto S, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol 2008;191:802-7.
-
(2008)
AJR Am J Roentgenol
, vol.191
, pp. 802-807
-
-
Laffan, T.A.1
Horton, K.M.2
Klein, A.P.3
Berlanstein, B.4
Siegelman, S.S.5
Kawamoto, S.6
-
43
-
-
84865080615
-
The pancreas cancer microenvironment
-
Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA. The pancreas cancer microenvironment. Clin Cancer Res 2012;18:4266-76.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4266-4276
-
-
Feig, C.1
Gopinathan, A.2
Neesse, A.3
Chan, D.S.4
Cook, N.5
Tuveson, D.A.6
|